ArticleJournal of robotic surgery2026
Development and validation of a LightGBM based machine learning model for predicting postoperative erectile dysfunction after robot assisted radical prostatectomy: a multicenter cohort study.
Article in Journal of robotic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Postoperative erectile dysfunction remains a highly debilitating complication following robot assisted radical prostatectomy for localized prostate cancer. Traditional risk stratification heavily relies on anatomical and oncological parameters utilizing simple linear regression algorithms, frequently failing to capture the complex multifaceted physiological and psychological dynamics that govern functional sexual recovery. To engineer and robustly validate an advanced machine learning architecture utilizing a LightGBM framework coupled with SHapley Additive exPlanations to accurately predict postoperative erectile dysfunction by integrating conventional surgical metrics with novel psychosocial and systemic immunological indices. This multicenter retrospective cohort study analyzed 824 patients with strictly localized prostate cancer who underwent robot assisted radical prostatectomy across two independent medical institutions. The primary outcome was functional erectile impairment systematically assessed utilizing validated questionnaires following a minimum six month postoperative observation period. To isolate the optimal prognostic variables, a rigorous two step dimensionality reduction strategy was executed. This approach incorporated Least Absolute Shrinkage and Selection Operator regression alongside a Random Forest feature importance algorithm. The dimensionality reduction pipeline successfully identified seven core independent predictors: the Patient Health Questionnaire 9 score, patient age, the HALP score, baseline serum testosterone, clinical stage, preoperative biopsy Gleason score, and prostate volume. The LightGBM algorithm demonstrated unparalleled predictive superiority in the independent validation cohort, achieving an area under the receiver operating characteristic curve of 0.946, an overall accuracy of 0.927, a sensitivity of 0.775, and a specificity of 0.956. The SHapley Additive exPlanations analysis provided transparent clinical interpretability, unequivocally revealing the Patient Health Questionnaire 9 score as the dominant predictive determinant. Severe baseline depressive symptoms were independently associated with a significantly elevated risk of functional impairment, whereas robust systemic nutritional immunological health and adequate baseline testosterone levels emerged as potential protective factors. This multicenter study developed a LightGBM prognostic framework that incorporates preoperative psychological and systemic physiological metrics to predict erectile dysfunction after robot assisted radical prostatectomy. The integration of these variables provides a more comprehensive approach to risk assessment than traditional physiological models. While further independent external validation remains necessary, this framework may assist urologists in personalized risk stratification and early rehabilitation planning for patients with localized prostate cancer.
Indexed as
Identifiers
42474603What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.